Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Görlitz

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Nature Methods|October 1, 2025
Fourier-based three-dimensional multistage transformer for aberration correction in multicellular specimensThayer Alshaabi, Daniel E Milkie, Gaoxiang Liu, et al.
Journal of Visualized Experiments : Jove|February 13, 2017
Open Source High Content Analysis Utilizing Automated Fluorescence Lifetime Imaging MicroscopyFrederik Görlitz, Douglas J Kelly, Sean C Warren, et al.
Arxiv|June 5, 2025
Fourier-Based 3D Multistage Transformer for Aberration Correction in Multicellular SpecimensThayer Alshaabi, Daniel E Milkie, Gaoxiang Liu, et al.
Pharmacopsychiatry|July 28, 2023
Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric TrialElias Wagner, Wolfgang Strube, Thomas Görlitz, et al.
Contemporary Clinical Trials Communications|February 20, 2020
Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trialAlkomiet Hasan, Astrid Roeh, Stefan Leucht, et al.
Communications Medicine|June 16, 2026
Antagonizing NRG1-ERBB4 signaling pathway with spironolactone for the treatment of schizophrenia: results of a randomized controlled drug repositioning clinical trialAlkomiet Hasan, Stefan Leucht, Astrid Roeh, et al.
Photochemistry and Photobiology|November 6, 2023
Assessing the safety of new germicidal far-UVC technologiesMaximilian Görlitz, Lennart Justen, Patrick J Rochette, et al.
Nature Communications|March 11, 2026
Acinetobacter baumannii's lifestyle includes soil-dwelling colonization of decaying plant material and airborne spreadGottfried Wilharm, Evelyn Skiebe, Andżelina Michalska, et al.
Nature Methods|May 22, 2026
A multimodal adaptive optical microscope for in vivo imaging from molecules to organismsTian-Ming Fu, Gaoxiang Liu, Daniel E Milkie, et al.
Translational Psychiatry|April 8, 2022
Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disordersC Okhuijsen-Pfeifer, M Z van der Horst, C A Bousman, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Nature Methods|October 1, 2025
Fourier-based three-dimensional multistage transformer for aberration correction in multicellular specimensThayer Alshaabi, Daniel E Milkie, Gaoxiang Liu, et al.
Journal of Visualized Experiments : Jove|February 13, 2017
Open Source High Content Analysis Utilizing Automated Fluorescence Lifetime Imaging MicroscopyFrederik Görlitz, Douglas J Kelly, Sean C Warren, et al.
Arxiv|June 5, 2025
Fourier-Based 3D Multistage Transformer for Aberration Correction in Multicellular SpecimensThayer Alshaabi, Daniel E Milkie, Gaoxiang Liu, et al.
Pharmacopsychiatry|July 28, 2023
Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric TrialElias Wagner, Wolfgang Strube, Thomas Görlitz, et al.
Contemporary Clinical Trials Communications|February 20, 2020
Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trialAlkomiet Hasan, Astrid Roeh, Stefan Leucht, et al.
Communications Medicine|June 16, 2026
Antagonizing NRG1-ERBB4 signaling pathway with spironolactone for the treatment of schizophrenia: results of a randomized controlled drug repositioning clinical trialAlkomiet Hasan, Stefan Leucht, Astrid Roeh, et al.
Photochemistry and Photobiology|November 6, 2023
Assessing the safety of new germicidal far-UVC technologiesMaximilian Görlitz, Lennart Justen, Patrick J Rochette, et al.
Nature Communications|March 11, 2026
Acinetobacter baumannii's lifestyle includes soil-dwelling colonization of decaying plant material and airborne spreadGottfried Wilharm, Evelyn Skiebe, Andżelina Michalska, et al.
Nature Methods|May 22, 2026
A multimodal adaptive optical microscope for in vivo imaging from molecules to organismsTian-Ming Fu, Gaoxiang Liu, Daniel E Milkie, et al.
Translational Psychiatry|April 8, 2022
Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disordersC Okhuijsen-Pfeifer, M Z van der Horst, C A Bousman, et al.
Pageof 13